StreetAlpha
Pennant Group, Inc. · SEC Form 4

PNTG Insider Trading

From SEC Form 412 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Pennant Group, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $698K sold.

← PNTG stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$698K7 sales · 3 insiders
Net−$698Kbought minus sold
Planned sales69%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJanFebMarApr2026-05: sold $158KMayJun2026-07: sold $260KJul2026-08: sold $272KAugSepOct2026-11: sold $8KNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when PNTG insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an PNTG officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every PNTG insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 17, 2026Jason Paul SteikChief Clinical OfficerSale plan218$37.15$8K14,888Nov 19Form 4
Aug 6, 2026Kirk Sterling CheneyEVP, GC and Corp SecySale1,393$38.52$54K18,401Aug 10Form 4
Aug 6, 2026Brent GuerisoliCEOSale4,285$38.52$165K99,544Aug 10Form 4
Aug 6, 2026Jason Paul SteikChief Clinical OfficerSale plan1,394$38.52$54K15,106Aug 10Form 4
Jul 10, 2026Brent GuerisoliCEOSale plan3,159$41.56$131K103,829Jul 14Form 4
Jul 7, 2026Brent GuerisoliCEOSale plan3,165$40.51$128K100,740Jul 9Form 4
May 22, 2026Brent GuerisoliCEOSale plan4,508$35.08$158K97,656May 27Form 4
Jul 28, 2025Kirk Sterling CheneyEVP, GC and Corp SecySale880$23.34$21K13,120Aug 7Form 4
Jul 28, 2025Brent GuerisoliCEOSale3,995$23.34$93K81,978Jul 31Form 4
May 20, 2025JoAnne StringfieldDirectorSale5,000$29.47$147K30,275May 23Form 4
May 1, 2025JoAnne StringfieldDirectorSale665$25.62$17K30,275May 5Form 4
Jan 30, 2025JoAnne StringfieldDirectorSale plan665$27.88$19K29,040Feb 3Form 4

PNTG insider trading FAQ

Are PNTG insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of PNTG on the open market in 0 trades, and 3 sold $698K in 7 trades, 69% of that under pre-arranged trading plans.

When did an PNTG insider last buy shares?

There has been no open market insider purchase of PNTG in the last two years.

When did an PNTG insider last sell shares?

Jason Paul Steik (Chief Clinical Officer) sold 218 shares for $8K on Nov 17, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice